[1] 曾波, 李彦. 慢性乙型肝炎和肝硬化患者血清骨桥蛋白和TGF-β1水平变化. 实用肝脏病杂志, 2017, 20:240-241. [2] 王烈, 胡义忠, 徐秀亮,等. 血清sP-selectin、sICAM-1和免疫球蛋白检测对乙肝肝硬化预后评估的意义. 中国免疫学杂志, 2017:1699-1705. [3] 王金波,李海英,孙敏等.乙肝肝硬化接受治疗期间肿瘤标志物水平的变化研究.中国实验诊断学,2016,20:1085-1088. [4] Gundogdu B, Yolbas S, Yilmaz M, et al. Serum osteopontin and vitronectin levels in systemic sclerosis. AdvClinExp Med, 2017,26:1231-1236. [5] 曾波,李彦.慢性乙型肝炎和肝硬化患者血清骨桥蛋白和TGF-β1水平变化.实用肝脏病杂志,2017,20:240-241. [6] 郭璐璐,贾超,曲彦,等.热休克蛋白70对缺血/缺氧嗜铬细胞瘤细胞细胞膜钙通道的调节机制.中华危重病急救医学,2016,28:314-318. [7] Zinserling VA, Esaulenko EV, Karev VE, et al. Clinical and morphological correlations in occult hepatitis B. ArkhPatol, 2017,79:8-13. [8] Semugoma NP, Rebe K, Sonderup MW, et al. Hepatitis C: A South African literature review and results from a burden of disease study among a cohort of drug-using men who have sex with men in Cape Town, South Africa. S Afr Med J, 2017,107:1116-1120. |